2018 Article Archive
A first-of-its-kind drug targeting a fused gene found in many types of cancer was effective in 93 percent of pediatric patients tested, researchers at UT Southwestern’s Simmons Cancer Center announced.
More than a dozen UT Southwestern Simmons Cancer Center researchers received awards from the Cancer Prevention and Research Institute of Texas (CPRIT) for research into breast, prostate, brain, kidney, liver, and pediatric cancers.
The Cancer Prevention and Research Institute of Texas (CPRIT) has awarded UT Southwestern researchers more than $27 million, including nearly $3 million for two key cancer screening programs in underserved areas
Researchers from UT Southwestern’s Charles and Jane Pak Center for Mineral Metabolism and Clinical Research and Internal Medicine’s Division of Nephrology recently published work in Nature that reveals the molecular structure of the so-called “anti-aging” protein alpha Klotho (Klotho) and how it transmits a hormonal signal that controls a variety of biologic processes.
UTSW study helps explain launch switch for most common malignant pediatric brain tumor.
UT Southwestern is one of the first in the United States to earn ACHA Adult Congenital Heart Disease (ACHD) accreditation
Scientists have found a genetic trigger that may improve the brain’s ability to heal from a range of debilitating conditions, from stroke to concussions and spinal cord injuries.
UT Southwestern Medical Center is implementing a program in Texas schools to address a startling rise in teen depression and suicide across the country.
Less nutritious dietary choices made by South Asians living in developed countries like the U.S. are a key contributor to the group’s rising rate of Type 2 diabetes, UT Southwestern researchers report.
A UT Southwestern study in mice provides new clues about how a class of anti-rejection drugs used after organ transplants may also slow the progression of early-stage Alzheimer’s disease.